Please assess the completion status of the following clinical trial:

Trial Title: Spironolactone After Liver Transplant

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* liver transplant~Exclusion Criteria:~* dual organ transplant

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- SOC-Standard of care (Type: NO_INTERVENTION): standard of care, nontreatment
- spironolactone (Type: EXPERIMENTAL): spironolactone

Based on this trial design, predict the completion outcome and termination type (if applicable).